Economist discuss surgical robotics landscape. Excludes orthopedic surgery and PCI spaces. Missing from discussion are Transenterix and Titan, former recently obtained FDA clearance and latter still in preclinical testing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.